| scholarly article | Q13442814 |
| P2093 | author name string | Williams J | |
| Gullick WJ | |||
| Fox H | |||
| Buckley CH | |||
| Hale RJ | |||
| Wilcox FL | |||
| P2860 | cites work | Structure and function of human amphiregulin: a member of the epidermal growth factor family | Q24292934 |
| Epidermal Growth Factor | Q34192014 | ||
| Prognostic value of c-erbB-2 expression in uterine cervical carcinoma | Q37111228 | ||
| Epidermal growth factor, its receptor, and related proteins | Q39500398 | ||
| The epidermal growth factor (EGF). | Q40133809 | ||
| Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas | Q41886819 | ||
| Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture | Q41918858 | ||
| Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina | Q42474871 | ||
| Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study | Q42518455 | ||
| Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins | Q42824683 | ||
| Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas | Q44590373 | ||
| Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation | Q44907727 | ||
| Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. | Q52559742 | ||
| Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix | Q56987817 | ||
| Epidermal growth factor requirement for development of cultured mammary gland | Q59077096 | ||
| Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement | Q67685799 | ||
| Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer | Q68149771 | ||
| Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues | Q68318652 | ||
| The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance | Q69571223 | ||
| The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas | Q69738247 | ||
| Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status | Q69816939 | ||
| Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer | Q69900051 | ||
| Epidermal growth factor receptor expression in gynecological malignancies | Q69953705 | ||
| Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels | Q70222255 | ||
| Cellular localisation of human epidermal growth factor receptor | Q72392851 | ||
| Epidermal growth factor receptors in human breast cancer | Q72396557 | ||
| Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes | Q72615984 | ||
| Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture | Q72957163 | ||
| Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal | Q79368389 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 149-153 | |
| P577 | publication date | 1993-02-01 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | Prognostic value of epidermal growth factor receptor expression in cervical carcinoma | |
| P478 | volume | 46 |
| Q38350767 | A rapid serological detection method for squamous cell carcinoma |
| Q33383385 | Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial |
| Q47610748 | Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix |
| Q73507208 | Detection of epidermal growth factor receptor mRNA in peripheral blood of cervical cancer patients |
| Q83125894 | Do tumor cavitation and sex in resected stage I non-small-cell lung cancer correlate with prognosis? |
| Q33359764 | EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy |
| Q80236088 | EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction |
| Q27851658 | EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target |
| Q40647554 | Epidermal growth factor increased the expression of alpha2beta1-integrin and modulated integrin-mediated signaling in human cervical adenocarcinoma cells |
| Q74266113 | Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer |
| Q37843137 | Epidermal growth factor receptor as a biomarker for cervical cancer |
| Q33832641 | Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results |
| Q40038133 | Epidermal growth factor receptor-targeted therapy. |
| Q33859549 | Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy |
| Q47872633 | Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis |
| Q42500625 | Expression of epidermal growth factor and platelet-derived growth factor receptors during cervical carcinogenesis |
| Q37722980 | Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes |
| Q78511667 | Genomics and proteomics: application of novel technology to early detection and prevention of cancer |
| Q43991563 | Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery |
| Q40963542 | Ki-67 Expression in a Cervical Cancer Organotypic Model Correlates with Growth and EGF-R Expression |
| Q33475963 | Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma. |
| Q38412448 | Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer. |
| Q38002719 | Molecularly targeted therapies in cervical cancer. A systematic review |
| Q35659915 | Monoclonal antibodies in gynecological cancer: a critical point of view |
| Q38804094 | Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients. |
| Q37487981 | Novel chemotherapy approaches for cervical cancer. |
| Q40125752 | Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease |
| Q47403683 | P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma |
| Q34850394 | Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study |
| Q42483596 | Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia. |
| Q64984907 | Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: evidence for down-regulation in cervical cancer. |
| Q43524729 | Therapeutic targets in radiotherapy |
| Q38106876 | Tumor cavitation among lung cancer patients receiving first-line chemotherapy at a tertiary care centre in India: association with histology and overall survival |
| Q37188066 | Update on novel therapeutic agents for cervical cancer |
Search more.